MGMichael Reid Gooch

Michael Reid Gooch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael Reid Gooch has a total of 523 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Tiny (≤3 mm) Unruptured Intracranial Aneurysms: A 13-Year Contemporary Insight on Treatment Safety From a Multicenter Registry

    by Victor Gabriel El-Hajj, Antony A. Fuleihan, Michael Rizzuto, James Castiglione, Joseph Schaefer, Arbaz Momin, Stephanie Serva, Ramesh Grandhi, Jonathan Grossberg, Brian M. Howard, et al.

    BACKGROUND AND OBJECTIVES: Tiny or very small unruptured intracranial aneurysms (≤3 mm) carry a very low estimated rupture risk, yet many are electively treated. Although factors influencing procedural risks have the potential to guide treatment selection, they remain poorly characterized in this population. METHODS: A retrospective cohort study was conducted using prospectively collected data from the multicenter Stroke Thrombectomy and Aneurysm Registry, including patients treated for unruptured aneurysms between 2013 and 2025. Tiny aneurysms were defined as ≤3 mm. Primary outcomes were intraprocedural and postprocedural complications. Propensity score matching and multivariable logistic regression were performed. RESULTS: Among 5107 treated aneurysms, 783 (15.3%) were tiny. Patients with tiny aneurysms were younger, more often female, and had higher rates of vascular risk factors, prior subarachnoid hemorrhage, or family history of aneurysms ( P < .05). Intraoperative complications (5.2% vs 5.1%, P = .91), postprocedural complications (8.4% vs 8.7%, P = .83), in-hospital mortality, and long-term outcomes were comparable with small (3-5 mm) aneurysms. On multivariable analysis, anterior communicating artery (odds ratio [OR] 4.92; 95% CI, 1.34-18.1; P = .016) and posterior communicating artery locations (OR 4.08; 95% CI, 1.40-11.9; P = .010), as well as stent-assisted coiling (OR 3.98; 95% CI, 1.33-11.9; P = .013) predicted intraoperative complications, while favorable preadmission functional status (modified Rankin Scale 0-1; OR 0.40; 95% CI, 0.21-0.76) predicted lower postprocedural complication risk. CONCLUSION: Treatment of tiny unruptured aneurysms remains common despite very low rupture risk. Procedural risks are low and comparable with slightly larger aneurysms. Treatment decisions should integrate both rupture risk and procedural safety, with anterior communicating artery or posterior communicating artery locations and unfavorable baseline functional status representing higher-risk features. When indicated, stent-assisted coiling was independently associated with higher intraoperative complication risk relative to clipping in this cohort.

  • Long-Term Recovery Trajectories After Endovascular Treatment of Carotid-Cavernous Fistulas: A Single-Center Cohort Study

    by Victor Gabriel El-Hajj, Maria Gharios, Joanna M. Roy, Basel Musmar, Jad El Choueiri, Wi Jin Kim, Nathaniel Ellens, Michael Rizzuto, Elias Atallah, Stavropoula Tjoumakaris, et al.

    BACKGROUND AND OBJECTIVES: Carotid-cavernous fistulas (CCFs) are uncommon arteriovenous shunts that can present with a wide range of nonspecific ophthalmic and neurological symptoms, often leading to diagnostic delays. While endovascular embolization is the primary treatment modality, data on long-term functional outcomes and the prognostic value of baseline symptom burden remain limited. METHODS: We conducted a retrospective single-center cohort study of consecutive patients with angiographically confirmed CCFs treated with endovascular embolization between 2009 and 2025. Clinical outcomes were assessed at early follow-up (median 1.5 months) and long-term follow-up (>1 year; median 52 months). Logistic regression analyses were used to evaluate the association between symptom burden, angiographic occlusion status, and failure of clinical improvement. RESULTS: A total of 107 patients were included (median age: 64 years, 35% male). Diagnostic delays were common (median duration from symptom onset to treatment: 30 days), frequently due to misdiagnosis as inflammatory, infectious, or vascular orbital conditions. Early follow-up demonstrated complete or partial improvement in 91% of patients, with significant progression from partial to complete improvement at long-term follow-up ( P = .001). Complication and repeat treatment rates were low. Neither symptom duration nor number of presenting symptoms was associated with failure of improvement at early or long-term follow-up ( P ≥ .05). Complete angiographic obliteration at the end of the procedure was associated with improved early outcomes (odds ratio 0.09; 95% CI, 0.02-0.39), while complete occlusion at last radiological follow-up predicted favorable long-term outcomes (odds ratio 0.15; 95% CI, 0.02-0.94). CONCLUSION: Endovascular embolization of CCFs is associated with excellent clinical outcomes and sustained long-term improvement. Symptom burden and diagnostic delays did not predict post-treatment recovery, whereas durable angiographic occlusion was a key determinant of outcome. These findings support intervention even in patients presenting late and emphasize the importance of achieving complete fistula occlusion.

  • Incidence and Predictors of Hemorrhagic Conversion After Mechanical Thrombectomy, Experience from a Large Comprehensive Stroke Center

    by Victor Gabriel El-Hajj, Maria Gharios, Joanna M. Roy, Basel Musmar, Deena Shefter, Christian Khoury, Wi Jin Kim, Michael Rizzuto, Nathaniel Ellens, Victor Romo, et al.

    BACKGROUND AND OBJECTIVES: Hemorrhagic conversion (HC) remains one of the most feared complications after mechanical thrombectomy (MT) for acute ischemic stroke and is associated with poor clinical outcomes. Evidence regarding predictors of HC after MT remains inconsistent. We sought to determine the incidence, predictors, and clinical impact of HC in a large contemporary cohort. METHODS: We conducted a retrospective analysis of a prospectively maintained database including consecutive patients who underwent MT for acute ischemic stroke between January 2016 and December 2024. Baseline clinical, radiographical, and procedural variables were collected. Outcomes were compared between patients with and without HC using 1:1 propensity score matching. Multivariable logistic regression was performed to identify independent predictors of HC. RESULTS: Among 896 patients undergoing MT, 267 (29.8%) experienced HC. After propensity score matching, HC remained associated with worse discharge neurological status (National Institutes of Health Stroke Scale 12.7 vs 9.6; P = .013), longer hospital length of stay (12.3 vs 9.9 days; P = .004), higher rates of decompressive craniectomy (9.4% vs 2.2%; P < .001), and increased likelihood of nonhome discharge (83% vs 71%; P < .001). In-hospital mortality was not significantly different after matching. On multivariable analysis, independent predictors of HC included higher admission National Institutes of Health Stroke Scale score (odds ratio [OR]: 1.04), diabetes mellitus (OR: 2.08), chronic kidney disease (OR: 1.76), and ≥3 thrombectomy passes (OR: 1.75). Increasing age (OR: 0.98), Black race (OR: 0.61), stent-retriever alone thrombectomy (OR: 0.53), and posterior circulation strokes (OR: 0.27) were all significantly associated with lower odds of HC. CONCLUSION: HC occurs in approximately one-third of patients undergoing MT and is independently associated with substantial neurological morbidity and healthcare utilization. Stroke severity, metabolic comorbidities, stroke location, and procedural complexity are key determinants of hemorrhagic risk. These findings support the need for enhanced risk stratification, and heightened postprocedural vigilance in high-risk patients.

  • The impact of BMI on mechanical thrombectomy outcomes, insights from a comprehensive stroke center

    by Victor Gabriel El-Hajj, Basel Musmar, Joanna M. Roy, Maria Gharios, Wi Jin Kim, Michael Rizzuto, Nathaniel Ellens, Stavropoula Tjoumakaris, M. Reid Gooch, Robert H. Rosenwasser, et al.

    Identifying predictors of outcomes following mechanical thrombectomy (MT) for stroke is crucial for selecting patients most likely to benefit from the treatment as well as guiding prognostication efforts. When it comes to the role of Body Mass Index (BMI) as a prognostic marker in that context, the evidence is conflicting. A retrospective analysis of a prospectively maintained database including patients undergoing MT between the 2016 and 2024 was performed. The main outcomes were functional recovery (discharge modified Rankin Scale (mRS); < 3 vs. ≥3), discharge National Institute of Health Stroke Scale (NIHSS) score, and in-hospital mortality. Multivariable regression and propensity score matching (PSM) were used. A total of 894 patients were included: 16 (1.8%) underweight, 298 (33%) normal weight, 291 (33%) overweight, and 289 (32%) obese (18% class 1, 8.8% class 2, and 4.9% class 3 obesity). On adjusted multivariable regression analyses, none of the BMI categories were associated with discharge mRS (p ≥ 0.05). However, underweight status was an independent positive predictor of both discharge NIHSS score (β = 8.5, 95% CI 3.5–14, p = 0.001), and in-hospital mortality (OR = 6.27, 95% CI 0.95–34.4, p = 0.040). No associations between either discharge NIHSS score or mortality and other BMI categories could be found (p ≥ 0.05). After PSM, no differences in terms of technical difficulty, including number of thrombectomy attempts, length of procedure, and reperfusion success, could be established on the basis of BMI (p ≥ 0.05). While obesity was associated with comparable outcomes compared to normal BMI, underweight status was shown to independently worsen outcomes following MT for stroke. Further studies are needed to establish the nature of this association.

  • Predictors of enucleation after intra-arterial chemotherapy for retinoblastoma

    by Joanna Roy, Victor Gabriel El-Hajj, Taweevat Attaseth, Annie Pan, Basel Musmar, Fady Bassem Fayek, Wi Jin Kim, Stavropoula I Tjoumakaris, Reid Gooch, Robert H Rosenwasser, et al.

    Background: Intra-arterial chemotherapy (IAC) has emerged as a minimally invasive treatment modality for globe salvage in patients with retinoblastoma (Rb). There is limited knowledge of the factors that influence rates of enucleation after IAC. Objective: Our study identifies predictors of enucleation among Rb patients receiving IAC. Methods: This was a retrospective study of Rb patients who received IAC between January 2010 and December 2024 at a single center in the United States. The primary outcome was enucleation at last follow-up. Results: Of 305 patients, 26.89% (n=82) underwent enucleation and 73.11% (n=223) did not. On multivariate analysis, factors associated with increased risk for enucleation were greatest basal diameter (OR 1.07, 95% CI 1.00 to 1.15, p=0.035), bilateral Rb (OR 2.82, 95% CI 1.36 to 5.81, p=0.005), and advanced-stage disease at presentation (OR 7.45, 95% CI 1.92 to 28.9, p=0.004). The use of combination chemotherapy was associated with lower odds for enucleation compared with single-agent chemotherapy (OR 0.29, 95% CI 0.11 to 0.80, p=0.016), whereas double-agent chemotherapy was not significantly associated with enucleation (OR 0.90, 95% CI 0.46 to 1.75, p=0.75). Conclusions: Larger tumors, bilateral disease, and advanced-stage disease were linked to higher odds of enucleation, whereas combination chemotherapy was associated with lower odds compared with single-agent chemotherapy. Future studies could help validate these results.

  • Venous sinus stenting versus ventriculoperitoneal shunting for idiopathic intracranial hypertension: propensity score weighted, cost consequence analysis

    by Victor Gabriel El-Hajj, Joanna Roy, Basel Musmar, Nassos Tziviskos, Arbaz A Momin, Wi Jin Kim, Michael Rizzuto, Nathaniel Ellens, Rabab Alshahrani, Elias Atallah, et al.

    Introduction Idiopathic intracranial hypertension (IIH) is characterized by elevated intracranial pressure, papilledema, and neurological symptoms. When medical management fails, treatment options include venous sinus stenting (VSS) and ventriculoperitoneal shunting (VPS). Comparative data on cost effectiveness remain limited. We aimed to compare clinical outcomes, healthcare utilization, and costs between VSS and VPS in patients with IIH using a propensity score weighted analysis. Methods This was a retrospective single center study. Baseline characteristics, complications, reoperations, unplanned 30 day emergency department visits and readmissions, unsatisfactory treatment response, salvage procedures, and inflation adjusted index procedure costs were collected. Propensity score weighting with overlap weights was applied to balance covariates. Weighted regression analyses were used to compare outcomes between groups. Results 139 patients were treated with VSS (n=99) or VPS (n=40). Baseline characteristics were well balanced after overlap weighting. Inflation adjusted index procedure costs and length of stay were similar between the VSS and VPS groups. VSS was associated with significantly lower rates of any complication (3.5% vs 37.7%, PConclusions While initial costs and clinical outcomes were similar, VPS was associated with higher complication rates, more revision related reoperations, and greater short term healthcare utilization. These findings suggest that VSS may provide a safer and more cost effective approach for patients with IIH who have failed medical therapy.


  • Middle meningeal artery embolization for chronic subdural hematoma using Nester pushable coils versus Onyx: a multicenter propensity score-matched analysis

    by Omar Ashraf, Basel Musmar, Kyle M Fargen, Allison Medina, Brock Yager, Mira Salih, Stacey Q Wolfe, Patrick Brown, Reid Gooch, Stavropoula I Tjoumakaris, et al.

    Background: Middle meningeal artery embolization (MMAE) has been shown to be an efficacious treatment for chronic subdural hematomas (cSDH). Liquid or particulate embolic agents are most commonly used, although coil embolization offers proximal vessel occlusions that may provide comparable efficacy. This multicenter propensity score-matched study compares outcomes of MMAE performed with Nester pushable coils versus Onyx. Methods: We retrospectively reviewed patients that underwent MMAE with either Nester coils or Onyx at two institutions between March 2019 and February 2025. Propensity score matching (1:1) was performed based on patient and hematoma characteristics. Primary outcomes included radiologic improvement or need for surgical rescue. Secondary outcomes included complication rate and procedure time. Results: A total of 183 patients were included (91 Nester coil, 92 Onyx) with similar baseline characteristics. More patients incurred general anesthesia for Onyx embolization compared with coiling (60.9% vs 15.4%; p < 0.001), although the patients that underwent coiling more often had bilateral embolization performed (64.8% vs 23.9%, p < 0.001). After propensity matching (n=67 per group), rates of radiologic improvement (>50% hematoma reduction), need for surgical rescue, and symptom recurrence were similar between the coil and Onyx cohorts (53.7% vs 44.8%, p=0.300; 14.5% vs 18.8%, p = 0.524, and 17.0% vs 15.9%, p = 0.872, respectively). Coil embolization had a significantly shorter median procedure time (34 vs 63 min, p<0.001) compared with Onyx embolization. Conclusions: Embolization using Nester pushable coils yields similar clinical outcomes to Onyx. Pushable coils are safe, efficient, and allow for shorter procedural times, providing an effective, cost-efficient option for cSDH.


  • Venous manometry triage in refractory idiopathic intracranial hypertension: imaging and criteria validity

    by Hsiangkuo Yuan, Areeba Nisar, Isha Sharan, Nivi Arunkumar, Jenny Chan, Enchao Qiu, Prabath Mondel, Neelu Jain, Kiran Talekar, Joga Chaganti, et al.

    Background and objective: Venous manometry (VM) is the reference standard for confirming hemodynamically significant transverse sinus stenosis (TSS) in idiopathic intracranial hypertension (IIH). However, no standardized approach exists for triaging refractory IIH (rIIH) patients for VM, and current IIH diagnostic criteria were not designed for this purpose. We evaluated the performance of established IIH diagnostic frameworks and imaging markers in detecting VM-confirmed TSS (vTSS). Methods: We retrospectively reviewed consecutive rIIH patients undergoing VM at a tertiary center (2022–2023). vTSS was defined as a trans-stenotic pressure gradient ≥8 mm Hg. Four IIH frameworks (Friedman 2013, modified Dandy 2014, Korsbæk 2023, and a modified 2023 schema), and predefined vascular and non-vascular MRI/MR venography signs were compared against vTSS. Results: Among 48 rIIH patients (mean age 38.9±9.9 years; all female; body mass index 36.8±9.1 kg/m²), vTSS was present in 33/48 (68.8%). Sensitivity/specificity for vTSS were: Friedman 2013 (78.6%/53.8%), modified Dandy 2014 (83.3%/60.0%), Korsbaek 2023 (90.6%/35.7%), and modified 2023 (93.5%/35.7%). Vascular imaging signs were highly sensitive (96.3%) across definitions; the modified 2023 vascular criteria achieved the highest specificity (42.9%). Five (15.2%) vTSS patients lacked papilledema. Conclusion: Current IIH frameworks vary in accuracy for detecting vTSS. 2023-based criteria maximize sensitivity for vTSS, while modified Dandy 2014 criteria offer greater specificity. Vascular imaging signs outperform non-vascular signs. These findings support incorporating standardized imaging protocols and refined triage algorithms to optimize VM referral in rIIH.

  • Comparative outcomes of middle meningeal artery embolization for chronic subdural hematoma: A comprehensive systematic review, meta-analysis, meta-regression and network meta-analysis

    by Basel Musmar, Joanna M Roy, Hammam Abdalrazeq, Stavropoula I Tjoumakaris, Michael Reid Gooch, Hekmat Zarzour, Ritam Ghosh, Richard F Schmidt, Robert H Rosenwasser, Pascal Jabbour

    Background: Middle meningeal artery embolization (MMAE) has emerged as a promising minimally invasive approach for chronic subdural hematoma (cSDH). We aimed to compare the effectiveness of middle meningeal artery embolization (MMAE) as a standalone therapy, MMAE combined with surgery, and surgery alone, while also compare embolic agents (Onyx, NBCA, particles), and access approaches (femoral vs. radial). Methods: We systematically searched PubMed, Scopus, and Web of Science through January 2025 for comparative studies focusing on MMAE and surgery in cSDH. Primary outcomes were recurrence and rescue surgery. Results: A total of 44 studies (39 observational and 5 randomized controlled trials) met inclusion criteria. MMAE alone (OR: 0.39; CI: 0.25 to 0.64) and adjunctive MMAE (OR: 0.40; CI: 0.29 to 0.55) had lower recurrence rates compared to surgery alone. However, there were no significant differences in complication rates or functional outcome (mRS 0–2) at the last follow-up. Onyx was associated with the lowest surgical rescue needs and radial access trended toward fewer access site complications compared to femoral access. Conclusion: MMAE, whether used alone or as an adjunct, is associated with significantly lower recurrence and fewer complications than surgery alone. Choice of embolic agent and radial access may also confer additional benefits. These findings emphasize the need for a comprehensive and tailored approach when utilizing MMAE to treat cSDH. Further studies are needed.


  • Multicenter comparative analysis of FRED-X, pipeline shield, and surpass evolve in treating intracranial aneurysms

    by Joanna M. Roy, Basel Musmar, Spyridon Karadimas, Matthews Lan, Sravanthi Koduri, Arbaz Momin, Alana McNulty, Alexandra Paul, Yi Zhang, Ajit S. Puri, et al.

    Background: In recent years, newer flow diverters have been developed with surface modification and varying wire densities. Our study evaluated outcomes among three newer generation flow diverter devices, FRED-X, PED Shield and Surpass Evolve. Methods: This was a retrospective study of patients from five participating institutions across the United States. Patients who underwent flow diversion of intracranial aneurysms using the FRED-X, PED Shield or Surpass Evolve between February 2022 and September 2024 were included. Outcomes of interest were technical success, angiographic occlusion and in-stent stenosis (ISS). Results: Among 447 patients with 452 aneurysms, adjunct device use was highest with Surpass Evolve (36.4%) versus PED Shield (15.7%) and FRED-X (6.4%) ( p < .001). Good wall apposition after angioplasty/stenting was most frequent with Surpass Evolve (32.3%) versus PED Shield (13.7%) and FRED-X (4.5%) ( p < .001). At six months, complete occlusion was achieved in 69.3% (PED Shield), 63.6% (FRED-X), and 58% (Surpass Evolve) ( p = .254). ISS rates were comparable at six months ( p = .826). At 12 months, complete occlusion was observed in 78.9% of PED Shield, 68.4% of FRED-X, and 64.5% of Surpass Evolve aneurysms. Most ISS cases at 12 months were mild. Kaplan-Meier analysis showed no significant difference in occlusion rates ( p = .914). Conclusions: Flow diversion using FRED-X, PED Shield and Surpass Evolve resulted in comparable rates of angiographic occlusion and ISS. However, adjunctive devices were more commonly needed with Surpass Evolve.